PE20071019A1 - Formulaciones farmaceuticas liquidas y semi-solidas que comprenden un modulador de receptores estrogenicos - Google Patents
Formulaciones farmaceuticas liquidas y semi-solidas que comprenden un modulador de receptores estrogenicosInfo
- Publication number
- PE20071019A1 PE20071019A1 PE2007000233A PE2007000233A PE20071019A1 PE 20071019 A1 PE20071019 A1 PE 20071019A1 PE 2007000233 A PE2007000233 A PE 2007000233A PE 2007000233 A PE2007000233 A PE 2007000233A PE 20071019 A1 PE20071019 A1 PE 20071019A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- composition
- weight
- amount
- semi
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE A FORMULACION FARMACEUTICA QUE COMPRENDE: A) UN COMPUESTO MODULADOR DE RECEPTORES ESTROGENICOS DE FORMULA (I) QUE SE ENCUENTRA EN UNA CANTIDAD DE 0,01% A 80% EN PESO DE LA COMPOSICION, DONDE R1 ES H, OH, HALOGENO, ALQUILO(C1-C6), ENTRE OTROS; R2 Y R2a SON CADA UNO H, HALOGENO, ALQUILO(C1-C6), ALCOXI(C1-C4), ENTRE OTROS; R3, R3a Y R4 SON CADA UNO H, ALQUILO(C1-C6), ALQUENILO(C2-C7), HALOGENO, ENTRE OTROS; X ES O, S O NR7, DONDE R7 ES H, ALQUILO(C1-C6), ARILO(C6-C10), ENTRE OTROS; SIENDO UN COMPUESTO PREFERIDO 2-(3-FLUOR-4-HIDROXIFENIL)-7-VINIL-1,3-BENZOXAZOL-5-OL; B) UN PRIMER VEHICULO TAL COMO LAUROIL MACROGOL GLICERIDOS, POLIETILEN GLICOL, ENTRE OTROS, QUE SE ENCUENTRA EN UNA CANTIDAD DE 10% A 99,99% EN PESO DE LA COMPOSICION; C) UN SEGUNDO VEHICULO TAL COMO LAUROIL MAGROGOL GLICERIDOS O CAPRILOCAPROIL MACROGOL GLICERIDOS, QUE SE ENCUENTRA EN UNA CANTIDAD DE HASTA 70% EN PESO DE LA COMPOSICION; D) UN EMULSIONANTE/SOLUBILIZANTE TAL COMO ESTER DE SORBITAN POLIETOXILADO QUE SE ENCUENTRA EN UNA CANTIDAD DE 0,01% A 30% EN PESO DE LA COMPOSICION; E) UN COMPONENTE ANTICRISTALIZACION/SOLUBILIZACION TAL COMO POLIVINILPIRROLIDONA QUE SE ENCUENTRA EN UNA CANTIDAD DE 0,01% A 30% EN PESO DE LA COMPOSICION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77984906P | 2006-03-06 | 2006-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20071019A1 true PE20071019A1 (es) | 2007-10-29 |
Family
ID=38475765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000233A PE20071019A1 (es) | 2006-03-06 | 2007-03-05 | Formulaciones farmaceuticas liquidas y semi-solidas que comprenden un modulador de receptores estrogenicos |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20070207201A1 (es) |
| AR (1) | AR059741A1 (es) |
| PE (1) | PE20071019A1 (es) |
| TW (1) | TW200800180A (es) |
| WO (1) | WO2007103869A2 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080175901A1 (en) * | 2006-11-21 | 2008-07-24 | Wyeth | Pharmaceutical formulations of a crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| US20080241234A1 (en) * | 2006-11-21 | 2008-10-02 | Wyeth | Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| US20080175900A1 (en) * | 2006-11-21 | 2008-07-24 | Wyeth | Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| US20090239920A1 (en) * | 2006-11-21 | 2009-09-24 | Wyeth | Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| GB2465746B (en) | 2008-11-21 | 2011-02-16 | Fortune Apex Dev Ltd | Pharmaceutical composition for topical application |
| MX336071B (es) * | 2009-08-14 | 2016-01-06 | Opko Health Inc | Formulaciones intravenosas de antagonistas de neurocinina 1. |
| JP2022523742A (ja) | 2019-02-01 | 2022-04-26 | ユニヴァーシティー オブ サウスカロライナ | 二環式ピリジン組成物およびがんの治療にそれを使用する方法 |
| US20220226343A1 (en) * | 2019-05-21 | 2022-07-21 | University Of South Carolina | 3-amino-4-[4-[4 (dimethylcarbamoyl) phenyl]-1,4-diazepan-1-yl]thieno[2,3-b]pyridine-2-carboxamide for use in cancer therapy and formulations comprising the same |
| US20230270714A1 (en) * | 2021-12-08 | 2023-08-31 | ATAI Life Sciences AG | Salvinorin compositions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3437599C2 (de) * | 1984-10-13 | 1987-04-16 | Dolorgiet GmbH & Co KG, 5205 St Augustin | Ibuprofen enthaltende Weichgelatinekapseln |
| US5468502A (en) * | 1994-12-20 | 1995-11-21 | American Home Products Corporation | Ibuprofen enhancing solvent system |
| US6878751B1 (en) * | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
| FR2818905A1 (fr) * | 2000-12-28 | 2002-07-05 | Cll Pharma | Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile |
| UA83620C2 (ru) * | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
| EP1781628A2 (en) * | 2004-08-26 | 2007-05-09 | Wyeth a Corporation of the State of Delaware | Prodrug substituted benzoxazoles as estrogenic agents |
| AU2005311823A1 (en) * | 2004-12-02 | 2006-06-08 | Wyeth | Formulations of substituted benzoxazoles |
| WO2006060384A2 (en) * | 2004-12-02 | 2006-06-08 | Wyeth | Formulations of substituted benzoxazoles |
| AU2005311833A1 (en) * | 2004-12-02 | 2006-06-08 | Wyeth | Formulations of substituted benzoxazoles |
| CA2600339A1 (en) * | 2005-03-08 | 2006-09-14 | Wyeth | Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| JP2009526851A (ja) * | 2006-02-14 | 2009-07-23 | ワイス | ＥＲβ選択的リガンドの水性薬学的配合物 |
-
2007
- 2007-03-05 TW TW096107513A patent/TW200800180A/zh unknown
- 2007-03-05 PE PE2007000233A patent/PE20071019A1/es not_active Application Discontinuation
- 2007-03-05 AR ARP070100902A patent/AR059741A1/es unknown
- 2007-03-05 US US11/682,120 patent/US20070207201A1/en not_active Abandoned
- 2007-03-05 WO PCT/US2007/063309 patent/WO2007103869A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AR059741A1 (es) | 2008-04-23 |
| US20070207201A1 (en) | 2007-09-06 |
| WO2007103869A3 (en) | 2007-12-06 |
| TW200800180A (en) | 2008-01-01 |
| WO2007103869A2 (en) | 2007-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20071019A1 (es) | Formulaciones farmaceuticas liquidas y semi-solidas que comprenden un modulador de receptores estrogenicos | |
| AR067673A1 (es) | Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas. | |
| PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
| AR060050A1 (es) | Compuestos moduladores del receptor de s1p y uso de los mismos | |
| PE20091621A1 (es) | Derivados de amina como moduladores de la actividad de tlr y composiciones que los contienen | |
| AR071609A1 (es) | Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1 | |
| PE20110028A1 (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
| PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
| AR069207A1 (es) | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 | |
| ATE430744T1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
| PE20071251A1 (es) | Derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
| AR061815A1 (es) | Compuesto de oxo-prolinamida composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento | |
| AR071959A1 (es) | Derivado de benceno o tiofeno y su uso como inhibidor de vap-1 | |
| UA94600C2 (en) | Indole sulfonamide modulators of progesterone receptors | |
| PE20060736A1 (es) | DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2 | |
| AR049262A1 (es) | Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias | |
| PE20070179A1 (es) | Derivados de purina como agonistas del receptor de adenosina a2 | |
| AR020551A2 (es) | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos. | |
| DOP2007000024A (es) | Composiciones herbicidas concentradas y estables | |
| PE20090890A1 (es) | Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c | |
| PE20081837A1 (es) | Derivados de quinuclinidol como antagonistas de los receptores muscarinicos | |
| PE20080117A1 (es) | Formulaciones farmaceuticas de una forma cristalina anhidra de 2-(3-fluor-4-hidroxifenil)-7-vinil-1,3-benzoxazol-5-ol | |
| PE20120113A1 (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| BRPI0509710A (pt) | formulação de liberação controlada para administração oral de inibidor de hmg-coa redutase e método para preparação da mesma | |
| PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |